GlucoMe

Digital Diabetes Management Solution

Health Tech & Life Sciences
Acquired (Inactive) by CuraLife on Jan 2021 - ceased to operate
Acquired Yarkona Founded 2013
LinkedIn
Total raised
Stage
Acquired
Founded
2013
Headcount
1
HQ
Yarkona
Sector
Health Tech & Life Sciences

About

GlucoMe is a digital health company developing and marketing a comprehensive digital solution for diabetes management. GlucoMe's algorithm-based decision-support system analyzes relevant diabetes data and provides medical teams with treatment recommendations, making up an autonomous diabetes heathcare platform. The GlucoMe solution enables smart and cost-effective remote care and monitoring, streamlining and simplifying diabetes care for patients, caregivers, and medical professionals. The platform integrates individual patient and population management to efficiently increase engagement and compliance. Its core architecture enables quick and simple implementation and allows organizations to easily scale up while delivering quality care. The GlucoMe platform includes an affordable wireless blood glucose monitor that operates with patented audio connectivity, a mobile app compatible with iOS and Android devices, a Digital Diabetes Clinic (cloud-based diabetes monitoring and control management software for healthcare organizations and professionals), and a Control Tower, which enables patient and population data-driven prioritization and management.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision SupportPatient Remote Monitoring
Technologies
Data StorageCloudArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2BB2B2CB2C

Highlights

1 PatentsVerified

Tags

digital-healthcareremote-monitoringmhealthpatientshealth-managementadherencehome-carediabetesmonitoringartificial-intelligencereal-timetelehealthmobile-applicationschronic-diseasehealthcare-providersiotchronic-patientspatent-pendingcloud-basedpersonalizationmachine-learningactionable-insightsmedical-devicesbig-datadata-analyticspatient-engagementmobile-platformtype-2-diabetesclinicsdecision-supportdoctorsdigital-therapeutics